Kancherla Medical Services Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 09-01-2025
- Paid Up Capital ₹ 0.15 M
as on 09-01-2025
- Company Age 23 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 24.48 Cr
as on 09-01-2025
- Revenue 2.23%
(FY 2022)
- Profit -69.48%
(FY 2022)
- Ebitda -16.14%
(FY 2022)
- Net Worth -0.09%
(FY 2022)
- Total Assets 0.06%
(FY 2022)
About Kancherla Medical Services
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.15 M.
The company has closed loans amounting to ₹24.48 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gopi Katteboyena and Harikrishna Uppada serve as directors at the Company.
- CIN/LLPIN
U65192TG2001PTC036456
- Company No.
036456
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kancherla Medical Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopi Katteboyena  | Whole-Time Director | 11-Jan-2018 | Current |
| Harikrishna Uppada | Additional Director | 28-Dec-2023 | Current |
Financial Performance of Kancherla Medical Services.
Kancherla Medical Services Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.23% increase. The company also saw a substantial fall in profitability, with a 69.48% decrease in profit. The company's net worth dipped by a decrease of 0.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kancherla Medical Services?
In 2020, Kancherla Medical Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 24 Jun 2016 | ₹5.53 Cr | Satisfied |
Indian Bank Creation Date: 25 Mar 2014 | ₹7.50 M | Satisfied |
Uco Bank Creation Date: 26 Feb 2014 | ₹4.95 Cr | Satisfied |
How Many Employees Work at Kancherla Medical Services?
Kancherla Medical Services has a workforce of 119 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kancherla Medical Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kancherla Medical Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
